The prevalence of gallbladder stones is higher among patients with chronic kidney disease in taiwan

Medicine

Volumn 88, Issue 1, 2009, Pages 46-51

  Lai, Shih Wei ^a   Liao, Kuan Fu ^a   Lai, Hsueh Chou ^a   Chou, Che Yi ^a   Cheng, Kao Chi ^a   Lai, Yen Miao ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CHOLELITHIASIS; CHRONIC KIDNEY DISEASE; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TAIWAN; CHRONIC KIDNEY FAILURE; COMORBIDITY; CROSS-SECTIONAL STUDY; GALLSTONE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GALLSTONES; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER CIRRHOSIS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 64949084191     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e318194183f     Document Type: Article

References (52)

1. Abu-Eshy SA, Mahfouz AA, Badr A, El Gamal MN, Al-Shehri MY, Salati MI, Rabie ME. Prevalence and risk factors of gallstone disease in a high altitude Saudi population. East Mediterr Health J. 2007;13:794-802.
2. Acalovschi M, Badea R, Dumitrascu D, Varga C. Prevalence of gallstones in liver cirrhosis: a sonographic survey. Am J Gastroenterol. 1988;83:954-956.
3. Altiparmak MR, Pamuk ON, Pamuk GE, Celik AF, Apaydin S, Cebi D, Mihmanli I, Erek E. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey. Am J Gastroenterol. 2003;98:813-820.
4. Badalamenti S, DeFazio C, Castelnovo C, Sangiovanni A, Como G, De Vecchi A, Graziani G, Colombo M, Ponticelli C. High prevalence of silent gallstone disease in dialysis patients. Nephron. 1994;66: 225-227.
5. Bektas A, Belet U, Kelkitli E, Bakir T, Acikgoz A, Akpolat T. Ultrasonic gallbladder function in chronic kidney disease: does predialysis, hemodialysis, or CAPD affect it? Ren Fail. 2005;27: 677-681.
6. Brasca AP, Pezzotto SM, Berli D, Villavicencio R, Fay O, Gianguzzo MP, Poletto L. Epidemiology of gallstone disease in Argentina: prevalences in the general population and European descendants. Dig Dis Sci. 2000;45:2392-2398.
7. Bureau of National Health Insurance, Taiwan. Available from URL: http://www.nhi.gov.tw/webdata/webdata.asp? menu=1&menu-id=&webdata-ID= 2122. Accessed April 2008.
8. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int. 1981;20:246-253.
9. Carey MC. Pathogenesis of gallstones. Am J Surg. 1993;165: 410-419.
10. Chang WY, Chen CJ, Lu SN, You SL, Chuang WL, Chen SC, Su WP, Wang LY, Hsieh MY, Wu MM. Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus. J Gastroenterol Hepatol. 1992;7:455-458.
11. Chawla A, Puthumana L, Thuluvath PJ. Autonomic dysfunction and cholelithiasis in patients with cirrhosis. Dig Dis Sci. 2001;46: 495-498.
12. Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, Yeh YH, Wu HS, Chou DA, Yueh SK. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol. 2006;21:1737-1743.
13. Chen CY, Lu CL, Huang YS, Tam TN, Chao Y, Chang FY, Lee SD. Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing. 1998;27:437-441.
14. Chen CY, Lu CL, Lee PC, Wang SS, Chang FY, Lee SD. The risk factors for gallstone disease among senior citizens: an Oriental study. Hepatogastroenterology. 1999;46:1607-1612.
15. Conte D, Fraquelli M, Fornari F, Lodi L, Bodini P, Buscarini L. Close relation between cirrhosis and gallstones: cross-sectional and longitudinal survey. Arch Intern Med. 1999;159:49-52.
16. Del Olmo JA, Garcia F, Serra MA, Maldonado L, Rodrigo JM. Prevalence and incidence of gallstones in liver cirrhosis. Scand J Gastroenterol. 1997;32:1061-1065.
17. Department of Health, Taiwan. Available from URL: http://www.doh.gov.tw/ CHT2006/DM/SEARCH-RESULT.aspx. Accessed April 2008.
18. Department of Health, Taiwan. Main Causes of Death in 2006. Available from URL: http://www.doh.gov.tw/EN2006/DM/DM2.aspx? now-fod-list-no= 9377&class-no=390&level-no=2. Accessed April 2008.
19. Diehl AK, Rosenthal M, Hazuda HP, Comeaux PJ, Stern MP. Socioeconomic status and the prevalence of clinical gallbladder disease. J Chronic Dis. 1985;38:1019-1026.
20. Gladziwa U, Wagner S, Kock R, Mann H, Sieberth HG. Sonographic evaluation of gallbladder motility in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant. 1992;7:840-843.
21. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735-2752.
22. Hahm JS, Lee HL, Park JY, Eun CS, Han DS, Choi HS. Prevalence of gallstone disease in patients with end-stage renal disease treated with hemodialysis in Korea. Hepatogastroenterology. 2003;50:1792-1795.
23. Ho KJ, Lin XZ, Yu SC, Chen JS, Wu CZ. Cholelithiasis in Taiwan. Gallstone characteristics, surgical incidence, bile lipid composition, and role of beta-glucuronidase. Dig Dis Sci. 1995;40:1963-1973.
24. Hojs R. Cholecystolithiasis in patients with end-stage renal disease treated with haemodialysis: a study of prevalence. Am J Nephrol. 1995;15:15-17.
25. Hsu CC, Hwang SJ, Wen CP, Chang HY, Chen T, Shiu RS, Horng SS, Chang YK, Yang WC. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis. 2006;48:727-738.
26. Jorgensen T, Jensen KH. Who has gallstones? Current epidemiologic studies. Nord Med. 1992;107:122-125.
27. Jorgensen T. Prevalence of gallstones in a Danish population. Am J Epidemiol. 1987;126:912-921.
28. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. National Kidney Foundation. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266.
29. Korzets Z, Golan E, Ben-Chitrit S, Schneider N, Chagnac A, Carel R, Bernheim J. Prevalence of cholelithiasis in non-diabetic haemodialysis and continuous ambulatory peritoneal dialysis patients. Nephron. 1998;78:44-47.
30. Lai SW, Ng KC. Risk factors for gallstone disease in a hospital-based study. South Med J. 2002;95:1419-1423.
31. Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC, Liaw YF. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound. 1993;21: 303-308.
32. Lin DY, Sheen IS, Chiu CT. Clinical significance of ultrasonographic fatty liver in asymptomatics: analysis of 1040 check-up subjects. J Med Ultrasound. 1993;1:165-171.
33. Lin SC, Shih SC, Kao CR, Chou SY. Prevalence of antibodies to hepatitis C virus in patients with nonalcoholic fatty liver. Zhonghua Yi Xue Za Zhi (Taipei). 1995;56:80-85.
34. Liu CM, Tung TH, Chou P, Chen VT, Hsu CT, Chien WS, Lin YT, Lu HF, Shih HC, Liu JH. Clinical correlation of gallstone disease in a Chinese population in Taiwan: experience at Cheng Hsin General Hospital. World J Gastroenterol. 2006;12: 1281-1286.
35. Lu SN, Chang WY, Wang LY, Hsieh MY, Chuang WL, Chen SC, Su WP, Tai TY, Wu MM, Chen CJ. Risk factors for gallstones among Chinese in Taiwan. A community sonographic survey. J Clin Gastroenterol. 1990;12:542-546.
36. Marzio L, Capone F, Neri M, Mezzetti A, De Angelis C, Cuccurullo F. Gallbladder kinetics in obese patients. Effect of a regular meal and low-calorie meal. Dig Dis Sci. 1988;33:4-9.
37. Maurer KR, Everhart JE, Knowler WC, Shawker TH, Roth HP. Risk factors for gallstone disease in the Hispanic populations of the United States. Am J Epidemiol. 1990;131:836-844.
38. Me'ndez-Sa'nchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-RodrI'guez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11:1653-1657.
39. Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K. Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA Project. Int J Obes. 1999;23:116-125.
40. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation. 2002;106: 3143-3421.
41. National Kidney Foundation in Taiwan. Available from URL: http://www.kidney.org.tw/a95.gif. Accessed April 2008.
42. Owyang C, Miller LJ, DiMagno EP, Brennan LA Jr, Go VL. Gastrointestinal hormone profile in renal insufficiency. Mayo Clin Proc. 1979;54:769-773.
43. Patankar R, Ozmen MM, Bailey IS, Johnson CD. Gallbladder motility, gallstones, and the surgeon. Dig Dis Sci. 1995;40: 2323-2335.
44. Pauletzki J, Althaus R, Holl J, Sackmann M, Paumgartner G. Gallbladder emptying and gallstone formation: a prospective study on gallstone recurrence. Gastroenterology. 1996;111:765-771.
45. Ravelli AM. Gastrointestinal function in chronic renal failure. Pediatr Nephrol. 1995;9:756-762.
46. Salinas G, Vela'squez C, Saavedra L, RamI'rez E, Angulo H, Tamayo JC, Orellana A, Huivin Z, Valdivia C, RodrI'guez W. Prevalence and risk factors for gallstone disease. Surg Laparosc Endosc Percutan Tech. 2004;14:250-253.
47. Shaffer EA, Small DM. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest. 1977;59:828-840.
48. Shaffer EA. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006;20:981-996.
49. Stroffolini T, Sagnelli E, Mele A, Cottone C, Almasio PL. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey. J Viral Hepat. 2007;14:618-623.
50. Tierney S, Pitt HA, Lillemoe KD. Physiology and pathophysiology of gallbladder motility. Surg Clin North Am. 1993;73:1267-1290.
51. United States Renal Data System 2007 Annual Data Report. Available from URL: http://www.usrds.org/2007/ pdf/00-intro-07.pdf. Accessed April 2008.
52. Xiao ZL, Chen Q, Amaral J, Biancani P, Jensen RT, Behar J. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am J Physiol. 1999;276: 1401-1407.